BioSpace News Archive

Business

Serum Institute and Aragen Bioscience Announce Collaboration on Vaccine Development

Aragen Bioscience, Inc and Serum Institute of India Pvt. Ltd. are pleased to announce a collaboration for the development of multiple stable cell lines to support Serum’s HIV program.

January 8, 2020
·
3 min read
Deals

Kaizen Health Announces Series B Funding Round To Support Nationwide Expansion

Kaizen Health, Inc. announced the completion of its Series B funding round led by UnityPoint Health Ventures, the venture investment arm of one of the nation’s most integrated health systems.

January 8, 2020
·
3 min read
Drug Development

Applied Therapeutics Announces Positive Topline Results of Pivotal Phase 2 ACTION-Galactosemia Study of AT-007 in Galactosemia Patients

AT-007 demonstrated a robust and sustained reduction in galactitol vs placebo; significant plasma galactitol reduction of ~50% (p<0.01)

January 8, 2020
·
7 min read
Policy

Aruvant Receives FDA Rare Pediatric Disease Designation for ARU-1801 for the Treatment of Sickle Cell Disease

ARU-1801 is being developed as a potential one-time treatment for patients suffering from sickle cell disease and β-thalassemia

January 8, 2020
·
3 min read
Business

Revitope Oncology Appoints Steve Arkinstall, D.Phil., as Chief Executive Officer

Revitope Oncology, Inc., a cancer therapeutics company advancing a novel class of tumor-specific bispecific antibody therapies, announced the appointment of Steve Arkinstall, D.Phil., as Chief Executive Officer.

January 8, 2020
·
3 min read
BioMidwest

Virtual Incision Announces $20 Million Financing to Advance First-of-its-Kind Surgical Mini-Robot

Company Files FDA IDE Submission for Confirmatory Clinical Study of MIRA Surgical Robotic Platform for Colectomy Procedures

January 8, 2020
·
5 min read
Drug Development

Airway Therapeutics Closes $15.5 Million Series C Financing to Advance Preclinical and Clinical Research and Development Programs to Prevent and Treat Serious Respiratory Diseases

Initiating bronchopulmonary dysplasia (BPD) clinical trial in very preterm infants in 2020 with orphan drug designation

January 8, 2020
·
5 min read
Roivant Sciences to Present at the 38th Annual J.P. Morgan Healthcare Conference

Roivant Sciences announced that Vivek Ramaswamy, Founder and Chief Executive Officer of Roivant, will present an overview of recent developments and future directions for the business at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

January 8, 2020
·
1 min read
Biotech Bay

Kodiak Sciences to Present at 38th Annual J.P. Morgan Healthcare Conference

Kodiak Sciences Inc. announced that management will present a company overview at the J.P. Morgan Healthcare Conference in San Francisco, California, on Tuesday, January 14, 2020 at 7:30 a.m. Pacific Time.

January 8, 2020
·
1 min read
ProMIS Neurosciences issues Chairman’s Update detailing positive outlook for Alzheimer’s disease therapy, pipeline in 2020

Anticipated approval of first amyloid-beta-targeting therapy to pave the way for next-generation therapies; PMN310 positioned as best-in-class against amyloid toxicity

January 8, 2020
·
4 min read